Day: October 6, 2021

NEW YORK, Oct. 06, 2021 (GLOBE NEWSWIRE) — Saratoga Investment Corp. (NYSE:SAR) (“Saratoga Investment” or “the Company”), a business development company, today announced that its wholly-owned subsidiary, Saratoga Investment Funding II LLC (“SIF II”), an entity formed for purposes of entering into this financing arrangement, closed a new $50.0 million senior secured credit facility (the “Facility”) with Encina Lender Finance, LLC (“Encina”). The Facility will be supported by loans held by SIF II and pledged to Encina under the terms of the credit agreement. The Facility closed on October 4, 2021. SIF II may request an increase in the commitment amount to up to $75.0 million during the first two years. The terms of the Facility require a minimum drawn amount of $12.5 million at all times during the first six months, which increases...

WILMINGTON, Del., Oct. 06, 2021 (GLOBE NEWSWIRE) — Navient (Nasdaq: NAVI), a leading provider of education loan management and business processing solutions, today announced it will release its 2021 third-quarter financial results on Navient.com/investors after market close on Tuesday, Oct. 26, 2021. Navient will host a conference call to review results on Wednesday, Oct. 27, 2021 at 8 a.m. ET. During the earnings call, Navient executives will further discuss Navient’s proposal to transfer its Department of Education servicing contract of government-owned loans to Maximus. For more information on that proposal, read the frequently asked questions now published at Navient.com/investors. Navient will notify investors when earnings results have been issued by a news release over a wire service and on Twitter @Navient. In addition,...

GARDEN CITY, NY, Oct. 06, 2021 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will be presenting virtually at the 14th Annual LD Micro Main Event Conference. Mr. Karkus will deliver his corporate presentation on October 14, 2021 at 9:30 AM ET. Register to watch the presentation here. About ProPhase LabsProPhase Labs (Nasdaq: PRPH) (“ProPhase”) is a diversified biotech and genomics company that seeks to leverage its CLIA lab services to provide whole genome sequencing and research direct to consumers and build a genomics data base to be used for further research. The Company continues to provide traditional CLIA molecular laboratory services, including COVID-19 testing. ProPhase Precision Medicine, Inc., focuses on genomics testing...

Increases in lumbar spine, femoral neck and total hip BMD demonstrated with EB613 Linear Dose Responses Seen in Biomarker and Bone Mineral Density Data Pivotal Phase 3 registration study expected to commence 2022 BOSTON and JERUSALEM, Oct. 06, 2021 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, presented the 6-month bone mineral density (BMD) data from its completed Phase 2 clinical trial of EB613, an oral formulation of human parathyroid hormone (1-34), or PTH, for the treatment of osteoporosis. The Late Breaking Presentation “A Six-month Phase 2 Study of Oral PTH in Postmenopausal Women with Low Bone Mass – 6 Month Bone Mineral Density (BMD) Results” was selected for a prestigious oral presentation, given by Entera’s Chief Medical Officer, Dr. Arthur...

ATLANTA, Oct. 06, 2021 (GLOBE NEWSWIRE) — Manhattan Associates Inc. (NASDAQ: MANH) today announced it will release its third quarter 2021 financial results on Tuesday, October 26, 2021, after the stock market closes. The press release will be followed by a conference call hosted by Manhattan Associates’ senior management at 4:30 p.m. Eastern time, also on October 26, 2021. Investors are invited to listen to a live webcast of the conference call through the investor relations section of the Manhattan Associates website at ir.manh.com. To listen to the live webcast, please go to the website at least 15 minutes before the call to download and install any necessary audio software. For those who cannot listen to the live broadcast, a replay can be accessed shortly after the call by dialing +1-855-859-2056 in the U.S. and Canada,...

Patents strengthen Acasti’s IP portfolio and provide protection through 2036 and 2037, respectively LAVAL, Québec, Oct. 06, 2021 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announces that the European Patent Office, Chinese Patent Office and the Mexican Patent Office have issued composition of matter patents for GTX-101, a novel bio-adhesive film forming topical spray formulation of bupivacaine for the treatment of Postherpetic Neuralgia (PHN). PHN is a persistent and often debilitating neuropathic pain caused by nerve damage from the varicella zoster virus (shingles), which may persist for months and even years. GTX-101 could provide significant benefits over the current standard of care including greater convenience, faster onset of action and longer duration of pain...

FLORHAM PARK, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s proprietary Versamune® T-cell activating technology, today announced that Matthew Hill will join PDS Biotech as its Chief Financial Officer (CFO) effective as of October 18, 2021, to lead the company’s financial strategy through its next phase of growth. Mr. Hill brings more than 25 years of experience in finance and operational leadership roles for life science companies. He is joining PDS Biotech after spending the last several years at Strata Skin Sciences (Nasdaq: SSKN) as their Chief Financial Officer, where he led the financial vision and strategy for the medical device company. Prior to joining Strata Skin Sciences, he held CFO roles...

Quanta, Inc.Figure 1.1BURBANK, Calif., Oct. 06, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Medolife Rx, Inc. (“Medolife”), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTCQB: QNTA), announced today that it has initiated a study on its polarized cannabidiol (CBD) muscle rub product, sold under the brand Aelia. The study will analyze the effectiveness of the product in reducing inflammation through the inhibition of cyclooxygenase-2 (COX-2) enzyme activity in the human body and compare the findings with other non-polarized CBD products currently available on the market. The study will take place under the supervision of a scientist from BCN Biosciences, Elizabeth Singer, PhD, whose expertise...

CHARLOTTE, N.C., Oct. 06, 2021 (GLOBE NEWSWIRE) — Ballantyne Strong (NYSE American: BTN) (the “Company” or “Ballantyne Strong”) today announced the appointments of Michael C. Mitchell and Larry G. Swets, Jr. to its Board of Directors. Mitchell has enjoyed a distinguished career as a financial professional, and most recently served as a Partner at Locust Wood Capital. He retired from the firm in 2019 after nine years in analytical positions in the consumer, industrial, real estate and media industries. From 2006 to 2011, Mr. Mitchell was a senior analyst at Breeden Capital LP, working with former SEC Chairman Richard C. Breeden, where he was primarily focused on consumer businesses and served as an advisor to the board of Applebee’s, a then-Nasdaq-listed restaurant operating company and franchisor and as an advisor to the board...